ReviewCancers2023

Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients.

Ewa Kalinka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.